Vir Biotechnology, Inc.·4

Feb 16, 6:56 PM ET

Pang Phillip 4

4 · Vir Biotechnology, Inc. · Filed Feb 16, 2024

Insider Transaction Report

Form 4
Period: 2024-02-16
Pang Phillip
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2024-02-16$10.24/sh3,321$34,006264,679 total
Footnotes (1)
  • [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.

Documents

1 file
  • 4
    wk-form4_1708127793.xmlPrimary

    FORM 4